738 related articles for article (PubMed ID: 29780391)
1. Concepts Collide: Genomic, Immune, and Microbial Influences on the Tumor Microenvironment and Response to Cancer Therapy.
Andrews MC; Reuben A; Gopalakrishnan V; Wargo JA
Front Immunol; 2018; 9():946. PubMed ID: 29780391
[TBL] [Abstract][Full Text] [Related]
2. The gut microbiome and cancer immunotherapeutics: A review of emerging data and implications for future gynecologic cancer research.
McKenzie ND; Hong H; Ahmad S; Holloway RW
Crit Rev Oncol Hematol; 2021 Jan; 157():103165. PubMed ID: 33227575
[TBL] [Abstract][Full Text] [Related]
3. Could the menagerie of the gut microbiome really cure cancer? Hope or hype.
Abid MB
J Immunother Cancer; 2019 Apr; 7(1):92. PubMed ID: 30940203
[TBL] [Abstract][Full Text] [Related]
4. Influence of gut and intratumoral microbiota on the immune microenvironment and anti-cancer therapy.
Chen Y; Liu B; Wei Y; Kuang DM
Pharmacol Res; 2021 Dec; 174():105966. PubMed ID: 34728366
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Intratumoral and Gastrointestinal Microbiota on Systemic Cancer Therapy.
Cogdill AP; Gaudreau PO; Arora R; Gopalakrishnan V; Wargo JA
Trends Immunol; 2018 Nov; 39(11):900-920. PubMed ID: 30392721
[TBL] [Abstract][Full Text] [Related]
6. Monitoring immune responses in the tumor microenvironment.
Wargo JA; Reddy SM; Reuben A; Sharma P
Curr Opin Immunol; 2016 Aug; 41():23-31. PubMed ID: 27240055
[TBL] [Abstract][Full Text] [Related]
7. Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy.
Qiu Q; Lin Y; Ma Y; Li X; Liang J; Chen Z; Liu K; Huang Y; Luo H; Huang R; Luo L
Front Immunol; 2020; 11():612202. PubMed ID: 33488618
[TBL] [Abstract][Full Text] [Related]
8. Tumor and Host Factors Controlling Antitumor Immunity and Efficacy of Cancer Immunotherapy.
Spranger S; Sivan A; Corrales L; Gajewski TF
Adv Immunol; 2016; 130():75-93. PubMed ID: 26923000
[TBL] [Abstract][Full Text] [Related]
9. The crosstalk between the gut microbiota and tumor immunity: Implications for cancer progression and treatment outcomes.
Wang M; Zhang L; Chang W; Zhang Y
Front Immunol; 2022; 13():1096551. PubMed ID: 36726985
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiome and adaptive immunity in schizophrenia.
Agorastos A; Bozikas VP
Psychiatriki; 2019; 30(3):189-192. PubMed ID: 31685450
[TBL] [Abstract][Full Text] [Related]
11. Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to Immunotherapy.
Xie F; Zhang J; Wang J; Reuben A; Xu W; Yi X; Varn FS; Ye Y; Cheng J; Yu M; Wang Y; Liu Y; Xie M; Du P; Ma K; Ma X; Zhou P; Yang S; Chen Y; Wang G; Xia X; Liao Z; Heymach JV; Wistuba II; Futreal PA; Ye K; Cheng C; Xia T
Clin Cancer Res; 2020 Jun; 26(12):2908-2920. PubMed ID: 31911545
[TBL] [Abstract][Full Text] [Related]
12. The Gut Microbiota in Causation, Detection, and Treatment of Cancer.
Murphy CL; OʼToole PW; Shanahan F
Am J Gastroenterol; 2019 Jul; 114(7):1036-1042. PubMed ID: 30848738
[TBL] [Abstract][Full Text] [Related]
13. Roles of microbiota in response to cancer immunotherapy.
Inamura K
Semin Cancer Biol; 2020 Oct; 65():164-175. PubMed ID: 31911189
[TBL] [Abstract][Full Text] [Related]
14. Compartmentalization of the host microbiome: how tumor microbiota shapes checkpoint immunotherapy outcome and offers therapeutic prospects.
Boesch M; Horvath L; Baty F; Pircher A; Wolf D; Spahn S; Straussman R; Tilg H; Brutsche MH
J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36343977
[TBL] [Abstract][Full Text] [Related]
15. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
[TBL] [Abstract][Full Text] [Related]
16. The microbiome, cancer, and cancer therapy.
Helmink BA; Khan MAW; Hermann A; Gopalakrishnan V; Wargo JA
Nat Med; 2019 Mar; 25(3):377-388. PubMed ID: 30842679
[TBL] [Abstract][Full Text] [Related]
17. Host⁻MicroRNA⁻Microbiota Interactions in Colorectal Cancer.
Yuan C; Steer CJ; Subramanian S
Genes (Basel); 2019 Apr; 10(4):. PubMed ID: 30987065
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota influence tumor development and Alter interactions with the human immune system.
Ge Y; Wang X; Guo Y; Yan J; Abuduwaili A; Aximujiang K; Yan J; Wu M
J Exp Clin Cancer Res; 2021 Jan; 40(1):42. PubMed ID: 33494784
[TBL] [Abstract][Full Text] [Related]
19. The Role of Gut Microbiota in Tumor Immunotherapy.
Wu M; Bai J; Ma C; Wei J; Du X
J Immunol Res; 2021; 2021():5061570. PubMed ID: 34485534
[TBL] [Abstract][Full Text] [Related]
20. Impact of gut microbiome in the development and treatment of pancreatic cancer: Newer insights.
Bangolo AI; Trivedi C; Jani I; Pender S; Khalid H; Alqinai B; Intisar A; Randhawa K; Moore J; De Deugd N; Faisal S; Suresh SB; Gopani P; Nagesh VK; Proverbs-Singh T; Weissman S
World J Gastroenterol; 2023 Jul; 29(25):3984-3998. PubMed ID: 37476590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
